Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Maitake D-Fraction is a standardized beta-glucan extract from Grifola frondosa mushrooms containing 1,3/1,6-beta-D-glucan as the primary bioactive compound. It enhances immune function by activating macrophages, natural killer cells, and T-helper cells through pattern recognition receptors.
Reported Benefits (Provisional)
Origin & History
Maitake D-Fraction is an extract from the Maitake mushroom, known for its potent beta-glucan content. It is produced through water extraction and concentration processes.
Research Narrative (Provisional)
Research on Maitake D-Fraction includes several studies demonstrating its immune-enhancing effects and potential benefits in cancer therapy, supported by preliminary RCTs.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Maitake D-Fraction is a standardized proteoglucan extract concentrated from Maitake mushroom (Grifola frondosa), primarily composed of beta-1,3/1,6-glucan polysaccharides bound to protein fractions (~15-30% protein by weight in the complex). The parent mushroom contains approximately 26-35g carbohydrates per 100g dry weight (predominantly beta-glucans at 15-25% dry weight), 15-25g protein per 100g dry weight containing all essential amino acids, and 3-5g dietary fiber per 100g fresh weight. Micronutrient content includes potassium (~200-300mg/100g fresh), phosphorus (~70-80mg/100g), copper (~0.3mg/100g), niacin (B3) (~6-7mg/100g dry), riboflavin (B2), and ergosterol (provitamin D2 precursor, ~100-400µg/g dry weight). The D-Fraction extract specifically concentrates the immunomodulatory beta-1,6-glucan backbone with beta-1,3 branch points, which are the primary bioactive compounds responsible for macrophage and T-cell activation via Dectin-1 receptor binding. Bioavailability note: the proteoglucan complex in D-Fraction shows enhanced oral bioavailability compared to crude mushroom powder due to its lower molecular weight fractions (~150-1,000 kDa), with sublingual or liquid forms demonstrating superior absorption over encapsulated powders.
Reported Mechanism (Provisional)
Maitake D-Fraction's beta-glucans bind to complement receptor 3 (CR3) and Toll-like receptors on immune cells, triggering cytokine release including IL-1β, TNF-α, and interferon-γ. This activation enhances macrophage phagocytic activity and stimulates natural killer cell cytotoxicity. The extract also modulates glucose metabolism by improving insulin receptor sensitivity and glucose transporter-4 translocation in muscle cells.
Clinical Narrative (Provisional)
Human studies include a 12-week trial with 32 diabetic patients showing 22-33% reduction in fasting glucose at 6g daily doses. Cancer research involves small pilot studies of 10-36 patients demonstrating enhanced immune markers and quality of life improvements when combined with chemotherapy. A randomized trial of 21 postmenopausal women found significant increases in natural killer cell activity after 12 weeks. Evidence remains preliminary with most studies being small-scale or uncontrolled.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.